Isometheptine/dichloralphenazone/paracetamol, sumatriptan comparable

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1297, 2001-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Isometheptene/dichloralphenazone/paracetamol: Intracerebral haemorrhage: case report

Reactions Weekly, Vol. 1, Iss. 1341, 2011-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Efficacy, end points and eventualities: sumatriptan/naproxen versus butalbital/paracetamol/caffeine in the treatment of migraine

By Fox Anthony W

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 5, 2012-09 ,pp. : 513-516

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Intranasal Sumatriptan

By Fuseau E.

Clinical Pharmacokinetics, Vol. 41, Iss. 11, 2002-01 ,pp. : 801-811

Adis International

Access to resources Recommend Favorite

Japanese launch for sumatriptan

Inpharma, Vol. 1, Iss. 1237, 2000-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Intranasal Sumatriptan: In Adolescents with Migraine

By Curran Monique P. Evans Hannah C. Wagstaff Antona J.

CNS Drugs, Vol. 19, Iss. 4, 2005-01 ,pp. : 335-343

Adis International

Access to resources Recommend Favorite